# Tacrolimus Versus Methotrexate as Rescue Therapy for Refractory Inflammatory Bowel Disease

> **NCT03204136** · — · UNKNOWN · sponsor: **Key Laboratory of Gastroenterology and Hepatology, Ministry of Health, China** · enrollment: 60 (estimated)

## Conditions studied

- Inflammatory Bowel Diseases

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03204136
- **Lead sponsor:** Key Laboratory of Gastroenterology and Hepatology, Ministry of Health, China
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-07-01
- **Primary completion:** 2019-04-01
- **Final completion:** 2019-12-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2017-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03204136

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03204136, "Tacrolimus Versus Methotrexate as Rescue Therapy for Refractory Inflammatory Bowel Disease". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03204136. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*